Loading...
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH). FDA-approved drug helps treat rare immunologic disease, study finds 05/17/2017 05:00 PM EDTNIH co-funded clinical trial tested alternative treatment for eosinophilic syndrome. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact NIHinfo@od.nih.gov. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health.
|
Loading...
Loading...